Article

Dual agents loaded polymeric nanoparticle: Effect of process variables

Deepak Sharma1, Gilphy Philip1, Reema Gabrani1, Javed Ali2, Shweta Dang1★★ Corresponding author

  1. 1Department of Biotechnology, Jaypee Institute of Information Technology, Noida, Uttar Pradesh, INDIA.
  2. 2Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi, INDIA.

CORRESPONDENCE

Shweta Dang

Department of Biotechnology, Jaypee Institute of Information Technology, Noida, Uttar Pradesh, INDIA.

shweta.dang@jiit.ac.in

Volume 5, Issue 3 · pp. 155–160 · PUBLISHED · DOI: 10.4103/2230-973X.160853

View on IJPI original site ↗

ABSTRACT

Aim and Objectives: In the present investigation dual agents i.e., hesperidin and diazepam loaded polymeric nanoparticles (NPs) were formulated by nanoprecipitation method and optimized using three-level factorial design. Methods: The developed NPs were optimized keeping poly (lactic-co-glycolic) acid (PLGA), poloxamer amount as independent process variable and z-average, percentage drug entrapment as a dependent response. The optimized NP was subjected to in vitro drug release study to investigate drug release mechanism from NP. Cell viability assay was performed on Vero cell line to confi rm the safety of NP. Results:Drug loaded NP showed z-average in the range of 189-307 d.nm with percentage drug entrapment for diazepam and hesperidin 62-89% and 68-92%, respectively. In vitro drug release studies showed controlled drug release behavior was observed from polymeric NP across dialysis membrane compared to aqueous drug solution. Cell viability assay showed drug dependent cytotoxicity on Vero cell line, however, polymeric NP showed less cytotoxicity compared with aqueous drug solution.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Sharma, D., Philip, G., Gabrani, R., Ali, J., & Dang, S. (). Dual agents loaded polymeric nanoparticle: Effect of process variables. International Journal of Pharmaceutical Investigation, 5(3), 155–160. https://doi.org/10.4103/2230-973X.160853